Author:

Keywords:

Clostridium Infections, Clostridium difficile, Colitis, Humans, Metronidazole, Vancomycin, Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, Clostridioides difficile, 1101 Medical Biochemistry and Metabolomics, 3202 Clinical sciences

Abstract:

Due to the growing incidence and the severity of infections due to vancomycin resistant enterococci, it is now recommended to treat mild to moderate cases of Clostridium difficile-associated diarrhoea with metronidazole while maintaining the use of oral vancomycin in serious or life-threatening colitis. Clostridium difficile is a common cause of diarrhoea after antibiotic therapy and induces a spectrum of diseases ranging from mild diarrhoea to pseudomembranous colitis (PMC). It is considered to be the first cause of diarrhoea occurring among hospitalized patients (1).